Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures

Launched by ACORN BIOLABS INC. · Jun 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the use of a special substance derived from hair follicles, called autologous hair follicle secretome (aHFS), to see if it can help reduce redness that often occurs after cosmetic procedures. The study is observational, meaning researchers will watch what happens in real-life situations without changing how procedures are done. They are currently recruiting participants aged 18 to 60 who are planning to have a cosmetic procedure and are interested in trying the aHFS product.

To be eligible for this trial, participants need to be in good health and not pregnant or breastfeeding. They should also not have used specific skincare products that could interfere with the study results. Participants can expect to share their experiences after their cosmetic procedures and how the aHFS product affects their recovery. This study aims to gather valuable information that could help improve post-procedural care for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male and Female,
• • Ages: 18-60
• • Any Fitzpatrick skin type
• • Planning a medical aesthetic procedure
• • Planning to use aHFS cosmetic product
• Exclusion Criteria:
• • Pregnant or Breastfeeding
• • Participation in an interventional clinical trial in the last 30 days
• • Use of other topical cosmetic products that may confound results
• • Use of retinoids within 7 days prior to facial procedure
• • Any health condition that in the investigator's opinion should preclude participation in study